Announcement PDF 604 Page 1 of 2 15 July 2001 Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder To Company Name/Scheme Alterity Therapeutics Limited ACN/ARSN 080 699 065 1. Details of substantial holder (1) The Bank of New York Mellon Corporation (BNYMC) and each Group Entity listed in Annexure A (Group Entity),(together BNYMC Group) Name ACN/ARSN (if applicable) There was a change in the interests of the substantial holder on 03/February/2025 The previous notice was given to the company on 02/May/2024 The previous notice was dated 01/May/2024 2. Previous and present voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows: Class of securities (4) Ordinary shares Previous notice Present notice Person’s votes Voting power (5) Person’s votes Voting power (5) 2,074,681,948 39.55% 2,266,681,474* 41.28%* *See Note 1 in Annexure C 3. Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: Date of change Person whose relevant interest changed Nature of change (6) Consideration given in relation to change (7) Class and number of securities affected Person's votes affected See Annexure B 4. Present relevant interests Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows: Holder of relevant interest See Annexure C Registered holder of securities Person entitled to be registered as holder (8) Nature of relevant interest (6) Class and number of securities Person's votes 604 Page 2 of 2 15 July 2001 5. Changes in association The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows: Name and ACN/ARSN (if applicable) Nature of association BNYMC and each Group Entity Each Group Entity is an associate of BNYMC pursuant to section 12(2)(a) of the Corporations Act 2001 (Cth) as each entity is directly or indirectly owned and controlled by BNYMC. 6. Addresses The addresses of persons named in this form are as follows: Name Address The Bank of New York Mellon Corporation 240 Greenwich Street, New York, NY 10286 USA Each Group Entity 240 Greenwich Street, New York, NY 10286 USA Signature print name sign here Andrew Weiser capacity Attorney-In-Fact date 04/February/2025 Annexure A This is Annexure A of 1 page referred to in Form 604 Notice of Change of Interests of Substantial Holder given by The Bank of New York Mellon Corporation and its related bodies corporate. The Bank of New York Mellon Corporation is the ultimate parent company of a corporate group comprised of a large number of operating and holding companies. Details of the entities directly owned and controlled by The Bank of New York Mellon Corporation are listed below. • • • The Bank of New York Mellon Pershing Group LLC Pershing LLC print name Andrew Weiser capacity______ Attorney-In-Fact 9sign here date 04/February/2025____________ Annexure B This is Annexure B of 1 page referred to in Form 604 Notice of Change of Interests of Substantial Holder given by The Bank of New York Mellon Corporation and its related bodies corporate Changes in relevant interests Date of change 9-May-2024 13-May-2024 18-Jul-2024 19-Jul-2024 5-Aug-2024 7-Aug-2024 10-Sep-2024 7-Oct-2024 25-Nov-2024 26-Nov-2024 2-Dec-2024 2-Dec-2024 2-Dec-2024 2-Dec-2024 2-Dec-2024 2-Dec-2024 2-Dec-2024 3-Dec-2024 4-Dec-2024 5-Dec-2024 9-Dec-2024 31-Dec-2024 2-Jan-2025 3-Jan-2025 6-Jan-2025 8-Jan-2025 9-Jan-2025 24-Jan-2025 28-Jan-2025 31-Jan-2025 3-Feb-2025 3-Feb-2025 Print Name -Andrew Weiser Sign Here Person whose relevant interest changed The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon Pershing LLC Pershing LLC Pershing LLC Pershing LLC Pershing LLC Pershing LLC The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon The Bank of New York Mellon Nature of Change Tranfer Out of securities Tranfer Out of securities Deposit of securities Tranfer Out of securities Deposit of securities Deposit of securities Deposit of securities Deposit of securities Tranfer Out of securities Tranfer Out of securities Tranfer Out of securities Purchase Purchase Purchase Sale Sale Sale Tranfer Out of securities Tranfer Out of securities Tranfer Out of securities Tranfer Out of securities Deposit of securities Deposit of securities Deposit of securities Deposit of securities Deposit of securities Deposit of securities Deposit of securities Tranfer Out of securities Deposit of securities Tranfer Out of securities Deposit of securities Capacity - Attorney-In-Fact Date - 04 February 2025 Consideration given in relation to change N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A USD 1.51 USD 1.515 USD 1.518 USD 1.51 USD 1.515 USD 1.518 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A Class and number of securities affected (Ordinary Shares) (2,844,600) (9,000,000) 75,220,800 (12,000,000) 3,000,000 5,400,000 3,060,000 6,000,000 (2,400,000) (3,000,000) (25,318,200) 129 ADRs (converted = 77,400 ord) 187 ADRs (converted = 112,200 ord) 1,000 ADRs (converted = 600,000 ord) (129) ADRs (converted = 77,400 ord) (187) ADRs (converted = 112,200 ord) (999.7894) ADRs (converted = 599,874 ord) (18,060,000) (9,000,000) (15,000,000) (750,000) 6,000,000 6,000,000 9,000,000 12,402,000 15,000,000 9,900,000 6,000,000 (3,000,000) 3,001,800 (31,854,600) 164,242,200 Person's votes affected (2,844,600) (9,000,000) 75,220,800 (12,000,000) 3,000,000 5,400,000 3,060,000 6,000,000 (2,400,000) (3,000,000) (25,318,200) 77,400 112,200 600,000 (77,400) (112,200) (599,874) (18,060,000) (9,000,000) (15,000,000) (750,000) 6,000,000 6,000,000 9,000,000 12,402,000 15,000,000 9,900,000 6,000,000 (3,000,000) 3,001,800 (31,854,600) 164,242,200 Annexure C This is Annexure C of 2 pages referred to in Form 604 Notice of Change of Interests of Substantial Holder given by The Bank of New York Mellon Corporation and its related bodies corporate Present relevant interests Holder of relevant interest The Bank of New York Mellon (BNYM) Nature of relevant interest Remote Interest Held Under Deposit Agreement Class and number of securities 2,266,680,748 ordinary shares Relevant interest under section 608(1)(c) of the Corporations Act 2001 (Cth) arising from BNYM having the limited power to dispose of, or control the exercise of a power to dispose of, securities deposited with or held by BNYM (or its custodian or agent) in its capacity as depositary administering an ADR program for Alterity Therapeutics Limited (Company) under the Deposit Agreement dated January 2, 2008 between the Company, holders of American depositary receipts (ADRs) and BNYM (Deposit Agreement). [*See Note 1 below]. BNYMC Group (other than BNYM) Relevant interest under section 608(3)(a) and/or 2,266,680,748 section 608(3)(b) of the Corporations Act 2001 (Cth) ordinary shares being a relevant interest held through a body corporate (namely BNYM) in which the voting power of each other entity in the BNYMC Group is above 20%, or that each other entity in the BNYMC Group controls. [*See Note 1 and Note 2 below] Pershing LLC Relevant interest under sections 608(1) of the Corporations Act 2001 (Cth) arising from Pershing LLC being the registered owner of the securities. 726 ordinary shares BNYMC Group (other than Pershing LLC) Relevant interest under section 608(3)(a) and/or section 608(3)(b) of the Corporations Act 2001 (Cth) being a relevant interest held through a body corporate (namely Pershing LLC) in which the voting power of each other entity in the BNYMC Group is above 20%, or that each other entity in the BNYMC Group controls. [*See Note 2 below] 726 ordinary shares NOTES: *Note 1: Of the total of 2,266,681,474 securities in which the BNYMC Group has a relevant interest, BNYM has a relevant interest in 2,266,680,748 securities as depositary for Alterity Therapeutics Limited ADR program administered under the Deposit Agreement. BNYM's relevant interest in these securities arises as a result of the Deposit Agreement containing rights for BNYM to dispose of securities held under the ADR program in limited circumstances. Under the Deposit Agreement, ADR holders retain their rights to dispose of those securities and to give voting instructions for the exercise of voting rights attached to the securities. BNYMC Group's power to vote or dispose of these securities is qualified accordingly. *Note 2: Each Group Entity is a direct or indirect wholly owned subsidiary of BNYMC, the ultimate parent company. Other than BNYM in respect of 2,266,680,748 securities (of which BNYM's power to only dispose of 2,266,680,748 securities is limited – see Note 1), and Pershing LLC in respect of 726 securities, none of the BNYMC Group entities are entitled to be registered as holder of the securities and their power to vote or dispose of the securities is qualified accordingly. print name Andrew Weiser capacity_ Attorney-In-Fact sign here date 04/February/2025__